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From Pioneering to Prognosis
Feature: From vision to illusion over disillusion 
to innovation
Innovations are fragile. What is called first vi-
sion easily turns to an illusion. Illusions have the 
moment of disorientation. That leads to disillusion. 
The fate of not overcoming that is clear. Frustration 
comes if high promises turn into dissatisfaction. If 
surviving, the status of an innovation has been 
reached.
The Frost & Sullivan research study entitled 
“European Lab-on-chip and Microfluidics Market” 
recommends that market participants need to ad-
dress interoperability concerns that keep pharma-
ceutical companies from readily including lab-on-
chip instruments in their existing workflows.1 
“Being a new technology that has to fit into an ex-
isting laboratory set up, it is essential that lab-on-
chip equipment is compatible with the pre-exist-
ing robotics and automation lay-out of the lab,” 
advises the analyst. “Companies that meet these 
standards will achieve greater success in attracting 
customers.
Déjà vu – visions inspire researchers
Why mentioning this here? Writing about bio-
technical micro-flow reactors is like a Déjà vu, 
something which comes again and again and again. 
At least for a senior scientist. Because it resembles 
what has been seen and experienced before. With 
their chemical counterparts – the ‘microreactors’ as 
these are shortly named. Some resistances have 
been surpassed here over 20-years development. 
Now, then same story starts again. Technology 
hype, dreams that blow away, hard work that finally 
turns into gold, demonstrated success. Like in the 
famous movie “Groundhog Day” which was re-
leased about 20 years ago and showing an endless 
repeated happening that occurs again each new day 
with exactly the same sequence – Déjà vu.2
Scientific psychology – Enthusiasm level
Such ‘eternal law’ is given for any scientific 
 innovation. Market analysts typically like to refer 
to the ‘Enthusiasm Level’ and plot it versus time 
(Fig. 1). Then it first increases rapidly, topping and 
falling pretty soon down into a deep valley of frus-
tration. Innovations which do not come out of here 
will dye and become illusions, fating away from 
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reality. Innovations which survive such danger 
through internal improvement and adaptation to re-
ality rise again to enthusiasm like the stock ex-
change market after deep depression. A good de-
scription has also been given here from a 
completely different angle, by youth leadership de-
velopment training.3 In a first phase, explaining the 
new idea is so important. It is a phase of developing 
identity, termed “forming”. The new technology is 
crystallized. Then demonstration is needed. The 
new technology turns out to be inferior to the 
well-researched long-lasting technology. This cre-
ates “storming” which easily can turn into frustra-
tion. Guidance is then necessary. Stop developments 
which lead to nowhere. Support developments 
which have the origin direction. This phase is 
termed “norming”. Finally, the true unique selling 
points are recognized. The phase of enabling starts 
and the time is there for “performing”.
In terms of “biotechnical micro-flow reactors” 
the four phases relate to (i) the formation of a scien-
tific community, (ii) the design and provision of the 
microfluidic devices with enzymes incorporated, 
(iiii) the first finding of true applications, and (iv) 
the emerge of a market with small companies and 
rising business.
The first author has experienced such phases 
for the development of chemical microreactors.4 It 
started 1993, yes, at that time the movie “Ground-
hog Day” was released. 20 years later, the Déjà vu 
is there with the biotechnical microreactors. For this 
reason, a review on this subject is given in the fol-
lowing. It is structured based on the technological 
enthusiasm phase assignment and will start for each 
of the chapters with a (personal) feature and then 
will give a scientific overview how detailed the de-
velopment is.
Theoretical potential analysis – 
review compilations
From chemical to biochemical microreactors
Microreactors are widely used in various or-
ganic syntheses, where their characteristics of en-
abling decreased time constants for mass and heat 
transfer and thereby improving selectivity and yield 
are the most pronounced.5 The biochemical synthe-
sis in microreactors is of more recent date, and fol-
lowed numerous analytical and diagnostic applica-
tions (such as Micro Total Analysis Systems 
(µ-TAS), enzyme linked immunosorbent assays 
(ELISAs) and enzyme-mediated protein fragmenta-
tion.6 Efficient use of small amounts of reagents 
and catalysts (and expensive enzymes) in develop-
ment studies is a clear motivation for the growing 
applications of microreactors in synthetic bio-or-
ganic chemistry.7
The development, optimization, and applica-
tion of micro-flow enzymatic reactors are expected 
to open a new era in bio-based processing.8 En-
zymes are known as sustainable chemo- and stereo-
selective catalysts that can significantly increase 
reaction selectivity and yield. The utilization of 
such smart synthesis in micro-flow allows to broad-
en the microreactor applications towards biocataly-
sis and biotechnology. Vice versa, microreactor pro-
cessing allows for a better control of specific 
reaction conditions, e.g. pH and temperature, which 
are very important for enzymatic activity.
The new field bio process engineering needs 
new types of reactors
In a review compilation, biotechnical mi-
cro-flow reactors are seen as a cornerstone in the 
emerging process intensification in biotechnology 
which has started around the turn of the century.9 
They are seen as counterpart to the successful trend 
in the chemical engineering area, where micro- and 
small-scale flow devices are used up to production 
scale. Some general information, stemming from 
the chemical microreactors is provided such as to 
discuss different designs, configurations and modes 
of operation of micro-flow reactors. Reference is 
also given to their use in downstream processing 
and the potential of integrating analytics. Current 
advantages and limitations in the use of micro-flow 
devices for process intensification are outlined and 
near-future developments are projected. The most 
valuable information, however, is a longer discus-
F i g .  1  – EDGE-type switches of enthusiasm level with growth 
in knowledge which presents also a time axis. Here 
for about ten years. EDGE = Explain, Demonstrate, 
Guide, Enable. Redrawn after3 and adapted to the 
content of this article.
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sion about several application studies of microstruc-
tured devices to bioprocesses. An (over several pag-
es) extended table summarizes even more first-hand 
information about the reactors used, enzyme immo-
bilization employed and a snapshot what the major 
outcome is.
Basic engineering features
The synthesis in enzymatic micro-flow reactors 
often needs longer residence time to achieve desired 
conversion.7 The design of such microreactor should, 
therefore, be such to allow for efficient residence time 
and a proper conversion level. The engineering of the 
enzymatic micro-flow reactors just has started. By far 
the most contributions so far were given from re-
searchers experienced in biocatalysis and thus chem-
istry. The following diagram shows operational win-
dows determined for enzymatic segmented flow as 
described in10 (and in this paper below in more detail) 
(Fig. 2). The Damköhler number (Da) and effective-
ness factor (E) were taken as main engineering pa-
rameters and so determine productivity (P). A feasible 
operational area is proposed (shaded area in Fig. 2).
Main further challenges for efficient use of en-
zymes are their short lifetime and mutual deactiva-
tion (in case of multi-step reactions). A develop-
ment of an efficient miniaturized flow system can 
enable a long term use of the biocatalysts, while the 
reactor milli-dimensions will facilitate the hydrody-
namics and the control of reaction conditions.11,12 
The advanced knowledge on immobilization tech-
niques, close control of operating conditions and 
factors that will increase productivity are important 
items to allow for tailoring of enzymatic flow reac-
tor design, and thereby to support process intensifi-
cation needs. It is important to note that benefit 
from the miniaturization can be found in other steps 
than conversion (such as efficient mixing and sepa-
ration).7,9 Thus, the issues of process integration 
and a holistic process design approach have consid-
erable importance.
Some observed advantages and challenges for 
using micro devices for conversion of biomolecules 
are shown in Fig. 3.12
Securing the innovation – 
Intellectual property rights
Patents on (chemical) microreactors
The patent development for chemical microre-
actors was for over ten years characterized by a 
strong linear increase in the number of patents 
filed.13,14 Both applied institutes and companies 
took the lead here.13 Initially, most patents came 
from Europe, here in particular from Germany, and 
from USA which had at that time the lead in the 
technological development.14 Later Japan, China 
and other countries took over the latter and also 
filed a number of patents.14 After about ten years 
the number of new patent applications settled to a 
constant level or even slightly decreased. Only a 
few devices were patented, probably because their 
design is most often not so generic and innovative 
over existing lab-chip and static mixer technology. 
In the first years of the chemical microreactors thus 
most patents were filed on complete laboratory 
bench-scale systems and numbered-up single reac-
tors for production.12 Concerning the latter, the Du-
Pont patent in 1995 was regarded as a landmark in 
the public attention, yet probably never reached that 
importance as well for the true technological imple-
mentation. It appears that there are too many cir-
cumventory solutions for the equipment and there is 
not the “one and only” solution which beats in per-
formance all others. Another point from today’s 
perspective is that the first microreactor systems 
patented were (by far) too visionary, generic (more 
F i g .  2  – Operational window diagram for segmented flow 
given in7 as determined by the Damköhler number (Da) and 
effectiveness factor (E), yielding productivity (P). The shaded 
area represents a feasible operational area (by permission of 
Wiley-VCH10).
F i g .  3  – Benefits and bottlenecks of using microreactor pro-
cessing for biocatalysis and other biotechnological 
operations (by permission of deGruyter12)
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on idea status, than being manufactured) and 
 complex to satisfy the needs of the chemist’s real 
world. 5–10 years later the second generation of 
manufacturers developed microreactor systems 
which are still in use in industrial practice and the 
developers probably have stronger patents for pro-
tection of their ideas. Lonza and Corning are pro-
found examples. A third patent claim direction be-
yond devices and systems, relates to processes. 
Merck in Germany was the first chemical company 
to massively file micro-reactor based process pat-
ents. A broad diversity of medicinal chemistry pat-
ents were filed and granted, all of which based on 
the claim that to the surprise and satisfaction of the 
researchers the microreactor process performed so 
well and maybe better than with conventional tech-
nology. Today, such patent strategy probably is not 
applicable anymore. It is well known and common-
ly accepted that microreactors are suitable tools for 
most of the chemistries and in some cases even can 
be used in production. Thus, a micro-flow pro-
cess-based patent probably has almost the same 
threshold in process innovation than has any other 
process patent (with conventional technology). Still 
there is probably enough room for such process pat-
ents, since microreactors allow to work under un-
usual conditions and even access novel process 
windows for which conventional technology cannot 
be used.
Forecast on patents on biotechnical micro-flow reactors
So far, only a few enzymes have been applied 
to microreactor-based process development, and 
only a few patents describe the construction of mi-
cro-flow enzymatic reactors, which is an indication 
that the field is still in its initial stage. A microreac-
tor that carries a silica-based nanoporous material–
enzyme composite, i.e. a microreactor using immo-
bilized enzymes, and a sandwich-structured 
enzymatic membrane reactor patent15 have been 
described in a patent review.14 Therein is also re-
ported about a US patent describing a microreactor 
system to perform a biocatalytic reaction with high 
yield, small enzyme/reactant ratio, and high rate 
(Fig. 4).16 The drawbacks of using enzymes in 
 solutions such as autolysis are overcome by filling 
the microchannels with functional beads. In this 
way, trypsin was introduced into the silicon micro-
reactor.
Following the above mentioned industrial 
trends for developing systems and processes rather 
than new microreactor devices,13 it is expected that 
in the near future new will happen also with bio-
technical micro-flow devices. Particularly for enzy-
matic micro-flow reactors potential for various 
combinations of innovations exists – many novel 
supports for enzyme immobilization, novel engi-
neered enzymes and microreactor devices are pat-
entable as individual innovations and also syner-
gistically. It appears that the system complexity 
of a biotechnological micro-flow benchtop plants 
and respective numbered-up devices for production 
is higher as given for their chemical counterparts. 
However, their mutual effects and benefits they 
bring to the entire process design have still not been 
addressed systematically. In the same way, good 
chances for patents in the field of biotechnical mi-
cro-flow processing are foreseen. Yet, the new 
 processing windows and challenges are not so 
well developed and not as clear as in chemistry. 
Maybe the overall processing chances are smaller, 
since the most important development target is 
yet not fully solved, which is to achieve sufficient 
pro ductivities in the small-scale micro-flow reac-
tors. In turn, naturally any major innovation here 
or in another central process issue can make 
big  impact at that time of development being in 
 infancy.
F i g .  4  – Schematic of a patented enzymatic micro-flow reac-
tor: 36) Channels 41–44, 46–48) reaction zones for fixing 
beads to immobilize the enzymes (not shown), 45) blocks, 50) 
wall. A: radius of a circle fitting a block; B, C: distance be-
tween the blocks; D, E: dimensions of reaction (by permission 
of Wiley-VCH16).
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Snapshot footprint on molecular diversity and 
performance achieved
In recent investigations, immobilized enzymes 
together with microfluidic devices have been ap-
plied in various hydrolysis and esterifications, C-C 
bond formation reactions, condensations and addi-
tions, oxidations and reductions, and polymeriza-
tion reactions.17 Some of these reactions associated 
with the conversion of biomolecules are collected in 
Table 2.
Technology fascination, technology 
infatuation, market uncertainness
Feature: From push to pull
Chemical microreactors initially were much in-
fluenced by the strong technological push coming 
from microtechnology and lab-chip technology.18 
The latter is persistent until today. Yet, what is good 
for one application – biochemistry and chemical 
analysis – does not have to be good for another ap-
plication such as synthetic chemistry. It took none-
theless quite long time until that has been received 
as common sense in the microreactor community. 
Likewise for the proper technology orientation, it 
took even longer time until clarity was there which 
objectives to reach best with microreactors and for 
which applications conventional technology still 
will be superior.
The enzymatic microreactor technology is ex-
actly in the same technology-market mismatch di-
lemma as chemical microreactors were about 15 
years ago. In the following the state of current de-
velopment will be shown in two chapters on “enzy-
matic lab chip applications” and first true “enzy-
matic micro-flow reactor concepts”. Finally, it will 
be shown that there is first light at the horizon. A 
chapter about first true “enzymatic micro-flow reac-
tor applications” will give an idea what origin ob-
jectives have been identified and what might be the 
markets in 5 to 10 years here.
An overview about some relevant researches 
with enzymatic micro-flow reactors giving some in-
sight in the main achievements claimed and is a 
snapshot on the technology performance level 
which will be further detailed downwards (Table 
1).9,12
Reactor design and systems assembly
Enzyme immobilization – technique optimization
A set of techniques were evaluated for the im-
mobilization of enzymes in microchannels made of 
polycarbonate.32 Physico-chemical immobilization 
on a layer of polyethyleneimine was found to be 
best suited and reproducible. In this way, alkaline 
phosphatase was entrapped into a tubular reactor. 
The known suitability of polycarbonate for industri-
al applications may offer chances for respective im-
plementation of future enzymatic micro-flow reac-
tor and its possible numbering-up.
Hierarchical porous monolithic rods
Monolithic silica rods of 4 mm diameter and 
2–5 cm length have uniform 3D hierarchical pore 
structure of high porosity, which is demonstrated by 
achieving very high flow rates up to about 1200 mL h–1 
at a pressure drop of 2.5 bar.33 The macropores and 
mesopores were 35 µm and ca. 20 nm wide, respec-
tively, and synthesized by sol–gel processing com-
bined to pore templating and phase separation (Fig. 
5). The enzyme invertase was immobilized on the 
silica rods and compared to mesoporous cellular 
foam-bound invertase for performance in the su-
crose hydrolysis. Michaelis–Menten kinetics were 
applied and it was found that the hydrolysis of su-
crose was more than 1000 times faster than given 
for invertase immobilized on mesoporous cellular 
foam. The invertase embedded in the mesopores of 
silica monoliths showed a remarkably larger affinity 
(lower KM) to the substrate than the native enzyme. 
Notable results were also achieved concerning pro-
cess stability and reliability. Storing the micro-flow 
F i g .  5  – SEM image of silica monolith surface morphology (A); TEM images of silica monoliths (B) and mesoporous cellular foam 
(C) structure (by permission of Elsevier33)
172 V. HESSEL et al., Biotechnical Micro-Flow Processing at the EDGE – Lessons to be…, Chem. Biochem. Eng. Q., 28 (2) 167–188 (2014)
reactors at 4 °C kept the initial activity constant for 
at least 6 weeks. When used for continuous opera-
tion, no change in performance was observed for at 
least 2 weeks.
Supramolecular enzyme supports – polymer brushes
Microfluidic glass chips were functionalized 
with poly(2-hydroxyethyl methacrylate) polymer 
brushes as anchors for co-immobilization of the en-
zymes glucose-oxidase and horseradish peroxi-
dase.34 In this cascade reaction glucose oxidase con-
verts D-glucose into δ-D-gluconolactone and 
hydrogen peroxide (Scheme 1).
Atomic force microscopy, FTIR spectroscospy, 
and field emission scanning microscopy were used for 
characterization of such supramolecular architecture. 
The enzyme-functionalized glass chips performed a 
bi-enzymatic cascade reaction to measure glucose in 
human blood samples with high selectivity and repro-
Ta b l e  1  – Some relevant researches with enzymatic micro-flow reactors for some insight in the main achievements claimed. This 
serves as a snapshot on the technology performance level. More examples and the references of these researches can be 
found in.9,12
Enzyme Reactor type/ immobilization method or fluid system Reaction type Outcome
β-glycosidase19
Stainless steel microreactor/ 
covalent binding by surface activation 
of the wall
Hydrolysis of lactose
More than 70 % conversion yield, 
can be used for reaction 




Stainless steel microreactor/ 
covalent binding by surface activation 
of the wall
β-Glucosylglycerol synthesis 
using cellobiose and glycerol




surface modification via silanization of 
inner wall using APTES and glutaraldehyde
Fumaric acid hydration to 
L-malic acid
25 % activity retention relative to 
that of free enzyme; Conversion 
yield up to 80 %
Lipase22
Borosilicate micro-capillary tubes/ 
thin film of lipase adsorbed on mesoporous 
silica coated on inner walls
Enantioselective 
transesterification of vinyl 
acetate
Long term operational stability, 
yield of 64 % with >99 % 
enantioselectivity
Lipase23
Silica microstructured optical fibers/ 
Covalent binding after silanization by 
APTES and glutaraldehyde used for 
cross-linkining 
Conversion of n-butanol 
to butyl laurate using 
Lauric acid
Yield up to 99 %, long term 
operational and storage stability, 
can be used at production scale
Yeast cells24
Glass, PS, PTFE, PFA and FEP micro-
channels/covalent binding on inner surface 
by silaninzation with APTES +cross-linking 
with glutaraldehyde
Surface activation of PS, 
FEP, PFA and PTFE
Round about 70 % cell coverage 
observed for all tested materials
Peptide-N-




Methacrylate based monolithic microreactor/
surface functionalization with glutathione 
via a succinimidyl-6-(iodoacetyl-amino)-
hexanoate
Removal of glycans from 
glycoproteins
By the use of oriented and 
non-oriented immobilization, 
complete deglycosylation achieved 
in seconds or in minutes
Cholesterol 
oxidase26
Glass microchip reactor/ 
aqueous phase (enzyme): n-heptane phase 
(substrate)
Cholesterol oxidation to 
4-cholestene-3-one
Around 70 % conversion, recovery 
of product in organic phase
Hydroxynitrile 
lyase27
Glass microchip reactor/ 




Conversion >90 % and 
enantioselectivity >99 %
Laccase28
Glass microchip reactor/ 
phosphate buffer (enzyme): phosphate 
buffer (L-DOPA)
Oxidation of L-DOPA Up to 87 % conversion within a short residence time of 100 seconds
Lipase29
Glass microchip reactor/ 
aqueous phase (enzyme): n-hexane phase 
(substrate)
Isoamyl synthesis using 
isoamyl alcohol and acetic 
acid
Around 35 % conversion, recovery 
of the product in organic phase
Lipase30
Glass microchip reactor/ 
aqueous phase (enzyme): n-decane phase 
(substrate)
Esterification of propionic 
acid to butyl propionate 
using 1-butanol
The reaction equilibrium shifted by 
recovery of the product in organic 
phase
Lipase31
Glass microchip reactor/ 
IL ([bmpyr][dca]) phase (lipase, isoamyl 
alcohol): IL ([bmpyr][dca]) phase (acetic 
anhydride; n-heptane)
Isoamyl acetate synthesis 
using isoamyl alcohol and 
acetic anhydride
Compared to batch 3 times increase 
in the reaction rate better 
productivity
L-DOPA: 3,4-dihydroxy-L-phenylalanine; IL: ionic liquid; [bmpyr][dca]: 1-butyl-3-methylpyridinium dicyanamide
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ducibility (Fig. 6). A fast analysis was reached in 20 s 
with a detection limit of 60 mM and the results agreed 
to analysis common to conventional hospital laboratory.
Foam made of silica nanowires (Nanosprings)
As smart enzyme support for threonine aldo-
lase, the high-surface area and high-porosity silica 
material Nanosprings (Fig. 7) was compared to the 
commercial polymeric support material Eupergit 
CM.35 The latter can be purchased as single beads 
to give a packed bed when filled in a mini tube. The 
first is available through chemical vapor deposition 
in sheet form, which simply can be cut further to 
any shape.36 By stacking block-type shape (e.g. cyl-
inder) can be realized, similar to monoliths. For Eu-
S c h e m e  1  – Multienzymatic cascade reaction using glucose-oxidase and horseradish peroxidase
F i g .  6  – Enzyme immobilization onto glass surface. From the first monolayer (a) via various chemical functionalizations (b) – (d) 
toward the co-immobilization of the two enzymes glucose-oxidase and horseradish peroxidase (by permission of Royal 
Society of Chemistry34).
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pergit CM, the share of chemically fixed enzymes 
and active enzymes were within the reported litera-
ture performance for enzyme immobilization. The 
values of immobilized enzymes on Nanosprings 
were somewhat lower. However, this is overcom-
pensated by the larger specific surface area of 
Nanosprings and the availability of a new, second 
generation flow reactor concept, which involves a 
tight packing of stacked Nanosprings disks.
Interconnection of reactor plates – bonding
Both a temperature-robust (trypsin) and tem-
perature-labile (pepsin) enzyme were patterned with 
little-to-no loss in enzyme activity.37 Such function-
alized PMMA microchips were sealed at 35 °C by a 
low-temperature solvent bonding system using 
methanol and water. High substrate/cover plate ad-
hesion strengths were achieved up to 4,000 kN m–2 
for unmodified PMMA substrates. In this way, pep-
sin was immobilized and encapsulated in a mi-
cro-flow reactor. Pepsin is a pH, temperature and 
solvent sensitive enzyme. Enzyme stability was de-
pendent on the functionalization method. When im-
mobilized water soluble carbodiimide considered 
only, a decrease of activity over a period of days 
was detected. In turn, immobilization with both wa-
ter soluble carbodiimide and N-hydroxysuccinimide 
allowed to remain activity even after a month of 
use. A high protein sequence coverage was achieved 
and short column lengths (10 mm) and respectively 
short residence time (a few seconds) sufficed for 
operation. The schematic diagram of both immobi-
lization methods has been shown in Fig. 8.
Community formation and forum 
for public-private partnership
Feature: No mirroring – no image
Although there has been microreactor research 
as early as in the late 80ies, this was centered in two 
research centers only and there were hardly any 
publications documented for about 4–5 years; at 
least not in chemical or chemical engineering litera-
ture.4 The very few papers published, not more than 
10 in total in peer-reviewed journals, targeted mi-
crofabrication literature and audience. The two in-
stitutions were the Kernforschungszentrum Karl-
sruhe KfK (now Karlsruhe Institute of Technology, 
south centrum, KIT) and the Pacific Northwest Na-
tional Laboratory, PNNL). PNNL worked for aero-
space and military applications mainly, both of 
which is quite prohibitive towards publishing. KIT 
had prime collaborations with a few companies in-
terested in thermal engineering such as Messer-
schmidt-Boelkow-Blohm.11
Community as mouthpiece for technology promotion
Two moments then gave the push needed to let 
such individual, scattered researches become a 
strong, widely recognized momentum and to give it 
a new name, establishing it as a new field. One was 
F i g .  7  – Morphology of silicon dioxide nanosprings before 
(top) and after (bottom) vapor-phase silanization 
(by permission of Wiley36)
F i g .  8  – A schematic representations of both methods of enzyme immobilization on the surface of PMMA
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the emerging of new research approaches which 
bundled together demanded for completion and a 
final counterpart. This was lab-chip technology, 
process intensification, and green chemistry; all of 
which started in the early 90ies. The second mo-
mentum was the formation of a conference series 
which served as platform for formation of a new 
scientific community and thereafter for communica-
tion and growth thereof.38 An initial workshop on 
the microreactor topic in 1994 and, motivated by 
the success, the 1st International Conference on Mi-
croreaction Technology (IMRET) in 1995 land-
marked the whole microreactor development almost 
20 years thereafter. Thus, there has to be a “need” 
and an “enabling moment”.
Biotechnology merges with miniaturization
Biotechnical micro-flow reactors needed the 
same to be recognized and to grow. The need comes 
here from the ever increasing importance of biocat-
alytic and biotechnical processing. The last push 
may come here from the biobased economy which 
will change all of chemistry’s platform chemicals. 
These days, enzymes are increasingly penetrating 
the chemical industry as catalysts for numerous re-
actions. The global market of enzymes was estimat-
ed at around US$1.5 billion in 2005.39a A growth of 
6.8 % annually is predicted to US$8.0 billion in 
2015.39b Experts predict a doubling in the next ten 
years, casually said, every forth chemical product 
stems from a biotechnical route. Naturally the most 
innovative reactor and processing concepts must 
adapt a disproportional share of such innovation, 
meaning biotechnology should have a leading role 
in the overall microreactor development. Until 4 
years or so ago, this was practically not given, how-
ever. Then, similar to their chemical counterparts, 
some scattered researches were reported enzymatic 
micro-flow reactors. Lastly, the momentum of hav-
ing a communication platform needs to be added. 
This has been the international conference on Im-
plementation of Microreactor Technology in Bio-
technology (IMTB). Meanwhile IMTB has become 
the platform as I remember IMRET being in the 
first years – with about 100–150 researchers and 
some new researchers coming and others leaving – 
having a core concept, yet not firm in all its direc-
tions – being between the disciplines, yet with re-
searchers not being truly interdisciplinary, being 
still rooted in the major discipline.
Miniaturization of biochemical analysis/sensing 
in microchips
Biochemical assays
L-Asparaginase was bound to monoliths and 
coatings which are part of enzymatic micro-flow 
chips. D,L-amino acids produced by the enzyme 
were chirally separated using microchip electropho-
resis with a laser induced detector.40 D,L-Aspartic 
acid (D,L-Asp) was used for a kinetic study for 
which a microchip electrophoresis–laser induced 
fluorescence method was set up. Further, a human 
serum containing L-asparagine (L-Asn) was hydro-
lyzed by the enzymatic chip. This was all done in 
the context of establishing a biochemical assay to 
eliminate unwanted side effects of the enzyme L-as-
paraginase when being applied as an anticancer 
drug to patients by injection. There are a number of 
these such as hepatic toxicity, allergic reaction, pan-
creatitis, central nervous system toxicity and de-
creased synthesis of blood clotting factors. A micro-
chip electrophoresis–laser induced fluorescence 
method was set up for a kinetics study of the enzy-
matic reaction. Thus, a first step has been made to-
wards an in vitro therapeutic method in an extracor-
poreal shunt system for acute lymphoblastic 
leukemia (ALL) treatment.
Proteomic sample processing
Miniaturization and automation in proteomic 
sample processing was the objective of researching 
proteolytic digestion in a digital enzymatic mi-
cro-flow reactor filled with hydrogels (agarose discs 
with immobilized trypsin or pepsin).41 The process-
ing was termed digital microfluidic (DMF) as it is 
based on moving and merging droplets (Fig. 9). 
Maximum digestion efficiency was achieved when 
using 31 g trypsin for 2-mm diameter discs. In an 
integrated method and using micro-flow droplet op-
F i g .  9  – Hydrogel proteolytic enzyme ‘microreactors’. Movie 
images (left) and a schematic (right) monitor a typical digestion 
in a 2-mm-diameter gel disc on a DMF (digital microfluidic) de-
vice. A 2 μL droplet containing a proteomic sample is delivered 
to the gel (a and b), actively incubated (c), dispensed from the 
gel (d), and then isolated (e) (by permission of Wiley41).
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eration, proteomic samples were sequentially re-
duced, alkylated, and digested. The trypsin gel discs 
resulted in higher sequence coverage as compared 
to conventional homogenous processing. A parallel 
digestion system was demonstrated by the simulta-
neous digestion of a single sample on multiple gel 
discs carrying different enzymes.
Proteolysis and digestion
Trypsin was covalently immobilized on a 
graphene oxide-silica composite coated channel wall 
in a PMMA microchip for efficient proteolysis.42 
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
and N-hydroxysuccinimide were used to crosslink 
trypsin via its amino groups to the carboxyl groups 
of the entrapped GO sheets (Fig. 10). The digestion 
time of hemoglobin, cytochrome c, myoglobin, and 
ovalbumin was notably reduced to 5 s. The se-
quence coverages were 95 %, 76 %, 69 %, and 
55 %, respectively. Moreover, the digestion of hu-
man serum demonstrated the suitability of using the 
functionalized chips for treating complex proteins.
Transfer intensification – merging with 
discipline and not loosing identity
Feature: Old wine is often the better one
Microreactors became strong when truly merg-
ing with reaction engineering and when the best re-
action engineers took them over. Today, the best 
chemists take microreactors over and the teaching 
of chemists is complemented with flow chemistry 
lecturing.43 Tomorrow the best biochemists will do. 
And bio process engineers will be truly needed. In 
the biotechnology the order of approaching has 
been upside down to the chemical counterparts. 
First, the biochemists, now the engineers are so 
much needed.
From multiple effects towards one-criteria focus
Microreactors traditionally were engineered by 
scientists from the fields of mechanical engineering 
and physics (rooting from the microelectronics 
main education streams) and later by scientists of 
the newly emerged field of microfluidics. Demon-
stration of effects was in the foreground.4 A variety 
of creative designs came out; yet often not with the 
chem eng goggles of minimizing pressure drop, 
fouling, backmixing, ensuring scaleability, and sim-
ply heading for the most efficient design as predict-
ed by common chem eng criteria and modern simu-
lation tools.
As a result, very targeted and focused studies 
are found these days, e.g. developing a multi-injec-
tion microreactor to minimize hot-spot formation by 
smearing reaction heat release over a large area.44 
Using a concept known in conventional chemical 
engineering and with using the same tools and virtu-
ally the same models a powerful tool is developed. In 
turn, the early microreactor papers contained a cor-
nucopia of research objectives. Naturally none fully 
developed. The direction just was not clear and ap-
proach was more playful. Publications on biotechni-
cal micro-flow still have such feature and go for 
many foci. Yet the high specialism of the research-
ers and their biochemical background has already 
led to an enhanced level of result achievement 
F i g .  1 0  – Preparation of CO-silica composite coating for immobilizing trypsin (by permission of Elsevier42)
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which made it possible to classify the researches in 
a manner introduced for the Novel Process Win-
dows concept.
In the following the three stages in intensifica-
tion will be discussed: (i) transfer, (ii) chemical and 
(iii) process-design based. The main focus of the 
research was taken for classification. Naturally this 
is not in each case fully rational. But the intention is 
here to give the reader insight in the multidimen-
sionity of bioprocess intensification at microscale, 
rather than heading for perfect assignment.
Mass transfer and residence time intensification
Segmented flow
Only a very few uses of a segmented mi-
cro-flow capillary reactor are so far reported, albeit 
this has been proven to be a powerful processing 
concept for chemical microreactors.10 To fill that 
gap a generic study was done for the enzyme-cata-
lyzed conversion of 1-heptaldehyde to 1-heptanol in 
a liquid-liquid phase system (Scheme 2). Relevant 
parameters for segmented flow such as capillary di-
ameter, flow velocity, phase ratio, and enzyme as 
well as substrate concentration were varied to show 
their impact on the enzymatic reaction. The sum of 
all this information led to the formulation of a novel 
operational window for an easy assessment of the 
various system constraints. Three coupled capillar-
ies of different diameter were finally arranged in 
series (Fig. 11).
In another example of segmented flow a simple 
method for making macroporous silica-monoliths 
with well-regulated porosity was used for the li-
pases immobilization to make an active and stable 
enzymatic microreactor. The reaction of hydrolysis 
of 4-nitrophenyl butyrate in water–decane media 
was selected. For the immobilized C. antarctica li-
pase A, 96 % conversion was obtained due to the 
significant increase in the interfacial activation oc-
curred by formation of favourable biphasic system. 
While only 23 % conversion for the free lipase was 
obtained. The stability of immobilized enzyme was 
also increased resulted in 64 % conversion at 80 °C 
and 70 % conversion when continuously run for 
480 hours.45
Some more examples on multiphase biotrans-
formations46 and enzymatic microreactors using 
non-aqueous media47 are reviewed.
Reaction rate enhancements
Catechol and L-DOPA oxidation/laccase
Laccases oxidise a wide range of substrates by 
radical mechanism accompanied by a reduction of 
oxygen to water in a four-electron transfer pro-
cess.48 The enzymatic oxidation of phenolic com-
pounds, catechol and L-DOPA, using commercial 
laccase (from Trametes versicolor) was performed 
in a micro-flow microreactor. At a residence time of 
72 s, a catechol conversion of 41 % and a L-DOPA 
conversion of 45 % were achieved, respectively. 
For catechol oxidation, the micro-flow based oxida-
tion rates were 76 to 704 g dm–3 d–1 which is 18 – 167 
fold higher as given for a macroreactor. Kinetic in-
vestigations showed that the maximum reaction rate 
achieved in micro-flow was two times higher than 
given for synthesis in a cuvette.
Selectivity
Regioselectivity
The regioselective acylation of the flavonoids 
naringin and naringin dihydrochalcone using Lipo-
zyme TL IM (from Thermomyces lanuginosus) was 
conducted in a micro-flow microreactor49 (Scheme 
S c h e m e  2  – TADH catalyzed reactions
F i g .  11  – Product generation at various reactant concentra-
tions opposed to schematic of coupled capillaries (2.15 mm, 
1 mm and 0.5 mm inner diameter) in series (by permission of 
Wiley-VCH10)
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3). The reaction conditions were mild (52 °C) and 
relatively short reaction times of 30 min were taken. 
High conversions up to 90 % and high regioselec-
tivities in the range of 99–100 % were achieved.
Enantioselectivity
A micro-flow packed-bed microreactor with 
threonine aldolase (TA) from Thermotoga maritima 
immobilized on a Eupergit support conducted the 
synthesis of phenylserine from benzaldehyde and 
glycine50 (Scheme 4). For immobilization two ways 
of different complexity were used, a so-called direct 
and an indirect method. The effects of temperature 
and residence time were studied in particular. The 
maximum yield of 35 % – due the equilibrium na-
ture of the reaction and substrate inhibition – is re-
alized both in the batch and flow process. In addi-
tion to using immobilized enzymes, a flow synthesis 
with free enzyme was realized. The product yield 
was slightly improved when operating under slug 
flow conditions. In all cases 20 % diastereomeric 
excess (de) and 99 % enantiomeric excess (ee) was 
observed. A stable run for 10 hours without enzyme 
deactivation was demonstrated at 70 °C and at 20 
minute residence time. The productivity of the reac-
tor was extrapolated to parallel run units and com-
pared with the result in a previous publication.
From those and other experimental results to-
gether with assumptions, calculations on the (theo-
retical) productivity of enzymatic micro-flow reac-
tors were made.35 This included results for the 
glucose oxidase immobilization on Nanosprings. 
High enzyme loadings and adequate space-time 
yields were the objectives. These productivities 
were benchmarked to industrial production targets 
for a high-value pharmaceutical intermediate (a di-
chiral amino alcohol, using threonine aldolase) and 
for a large-volume fine-chemical (gluconic acid, us-
ing glucose oxidase). This shows that the present 
loading performance suffices (at best) for making 
high-value products, such as pharmaceuticals, but 
not for larger-volume, low-cost chemicals.
Productivity – scale out
Micro-flow packed bed reactor
A packed micro-flow – bed reactor comprised 
acid phosphatase which was covalently immobi-
lized on PMMA beads with an epoxy linker (Im-
mobeads-150 or Sepabeads EC-EP).51 After immo-
bilization 70 % of the activity was retained and 
stability was given for many months. The enzyme 
S c h e m e  3  – Lipase-catalyzed regioselective acylation of naringin and naringin dihydrochalcone in microreactors
S c h e m e  4  – Phenylserine synthesis using threonine aldolase in a micro-flow packed-bed microreactor
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catalyzed the transfer of a phosphate group from 
pyrophosphate to different molecules with primary 
alcohol groups. This included glucose-6-phosphate, 
N-acetyl-D-glucosamine-6-phosphate, allyl phosphate, 
dihydroxyacetone phosphate, glycerol-1-phosphate, 
and inosine-5’-monophosphate. Operation on a 
gram scale was achieved.
Via kinetic analysis and higher enzyme loading 
towards conversion-rate intensification
A packed micro-flow – bed reactor was com-
pared to the batch slurry reactor for the transesteri-
fication of ethyl butyrate with 1-butanol to give bu-
tyl butyrate catalyzed by Candida antarctica Lipase 
B (CALB) in Novozym 43552 (Scheme 5).
Novozym 435 was stable up to 80 °C in the 
micro-flow packed bed reactor. Stable 12 h opera-
tion at 70 °C was achieved, without enzyme deacti-
vation. External and intra-particle transport limita-
tions notably impact the observed reaction rate. The 
same packing can be reused for several days with-
out activity loss.
A complete kinetic description allows to make 
use of transfer intensification in the micro-flow re-
actor stemming from higher specific enzyme load-
ing, shorter diffusion pathway, with low reactant 
molar ratio (ethyl butyrate:1-butanol) and use of 
high concentration. This results in higher overall 
conversion and higher reaction rate per unit of catalyst 
volume. Total conversion was achieved in approxi-
mately 4 min residence time giving 0.04 mol L–1 of 
product, while in batch more than 30 min were 
needed for maximum conversion of 87 % (Fig. 12). 
An outline on enzymatic microreactor production 
performance is given.
Fed batch in flow – multi-input reactor
While chemical microreactors typically per-
form best at high concentrations or even in sol-
vent-free operation, biocatalytic pathways suffer 
Ta b l e  2  – Different micro-flow reactors used in35 and some key data on enzymes and support. This is used to extrapolate to (theo-
retical) reactor productivities. GOT: glucose oxidase; TA: threonine aldolase (by permission of Elsevier35).
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S c h e m e  5  – Transesterification reaction of ethyl butyrate and 1-butanol using Novozym 435
F i g .  1 2  – Conversion for batch and packed-bed micro-flow 
reactor at 60 °C. (■) Microreactor; 0.04 M EB, 0.4 M B; 
(♦) Batch reactor: 0.04 M EB, 0.2 M B in t-BuOH as a solvent. 
EB: ethyl butyrate, B: 1-butanol (by permission of American 
Chemical Society52)
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from adverse effects of high substrate concentration 
on the biocatalyst, including inhibition and denatur-
ation.53 Thus, to achieve high productivity remains 
an open question. A solution to this is provided by 
fed-batch reactors and thus it is advised to search 
for micro-flow analogues. To realize this, a multi-input 
microfluidic reactor was developed which is capable 
of substrate feeding at multiple points (Fig. 13).
The transketolase-catalysed reaction of lithium 
hydroxypyruvate and glycolaldehyde to l-erythru-
lose was investigated (Scheme 6). A 4.5-fold in-
crease in output concentration and a 5-fold increase 
in throughput was achieved compared with a single 
input reactor.
Chemistry intensification – 
push enzymes to their limits
Out of the niche and become accepted
There was a time when chemical microreactors 
were considered to be niche applications.4 Only a 
few chemical reactions seemed “to keep speed” 
with the fast-tuneable chemical microreactors. 
Meanwhile it is known how to speed chemical reac-
tions; actually by virtue of utilizing the transport 
intensification enabled by the microreactors. That 
was game changing and is a main result of the 
chemists entering the microreactor world in the 
shape of the flow chemistry development. While the 
catalytic action of enzymes seem to be suited only 
for slow reactions, first examples give some hope 
that at least “niches” for sufficient productivity ex-
ist. Assuming similarity to the chemical microreac-
tor development and finding of similar (or other 
new) intensification means, there might be a larger 
use of the enzymatic micro-flow reactor for future’s 
production needs. This development is regarded to 
be much more relevant than to further optimize the 
transport intensification means.
Bioflow chemistry – optimization 
of process conditions
Concentration – enzyme and coenzyme
The enzymatic oxidation of hexanol to hexanal 
(as green note fragrance) using NAD+ dependent 
commercial alcohol dehydrogenase (from S. cerevi-
siae) was performed in tubular micro-flow micro-
reactors with internal volumes of 6 and 13 µL.54 
Another tubular micro-flow microreactor with a 
volume of 2 µL internally comprised micromixers, 
as one had to deal with mass transfer in immiscible 
phases. The impact of enzyme and coenzyme inlet 
concentrations and flow ratios on the conversion of 
hexanol and the volumetric productivity of hexanal 
was analyzed. Best result was achieved for c (hexa-
nol) = 5.5 mmol L–1, c (NAD+) = 0.55 mmol L–1, 
and c (NADH) = 0.092 g L–1 which outperformed 
the batch processing. 12 % conversion of hexanol 
was given for the 6 µL microreactor after 72 s, 
whereas the macroscale reactor had only 5 % con-
version after 180 s.
Preconditioning – of enzyme and substrate ratio
A preconditioning study utilized mixing en-
zyme and substrate in predefined ratio before reac-
tion and enabled so a millisecond temporal analysis 
of enzymatic reactions.55 Crucial element was a mi-
cromixer generating four lamination layers through 
a narrow channel, thereby reducing the diffusion 
lengths to a few micrometers and providing mixing 
times in the millisecond range. In this way, the en-
zymatic hydrolysis using β-galactosidase was per-
formed using enzyme/substrate ratio from 1:1 up to 
3:1. Kinetic data collection was achieved in a very 
short time in the order of minutes. The fast and easy 
F i g .  1 3  – Multi-input microfluidic reactor for multiple sub-
strate feeding (by permission of Elsevier53)
S c h e m e  6  – Reaction of lithium hydroxypyruvate (HPA) and glycolaldehyde (GA) to l-erythrulose (ERY) using transketolase
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handling of the mixing device makes it a very pow-
erful and convenient instrument for millisecond 
temporal analysis of bioreactions. The enzymatic ac-
tivity determination of β-galactosidase was done by 
optical measurements using fluorescein di-(β-D-ga-
lactopyranoside) (FDG) as a substrate which gets 
converted to fluorescein and galactose by sequential 
hydrolysis (Scheme 7).
Process-design intensification – 
push enzymes to their limits
Essay: Two is more than one, 
synergy of integration
One ‘relict’ from miniaturization remains as 
big advantage for chemical and biotechological mi-
cro-flow reactors, even if these cannot give transfer 
or chemical intensification. Their smallness allows 
for compact process designs. The big commercial 
success of microelectronics stems from the system 
integration in the microprocessor as central element 
of every computer. Same for microchemistry. The 
compact process integration achievable can go be-
yond conventional process integration and is often 
accompanied by process simplification.56,57 Integra-
tion can be hierarchical from device to system to 
full-plant level. As a net result, synergy is achieved, 
e.g. when coupling of reaction to extraction or en-
dothermic reactions to exothermic ones.57
The closer the developments go to industrial 
level, the more attention will be given towards the 
process-design improvement with the specific pos-
sibility the compactness allows. Some of which is 
given in the following.
Coupling of micro-flow enzymatic reactions 
to micro-flow separation
Micro-flow extraction – hydroxylation of progesterone/ 
Rhizopus nigricans
The hydroxylation of progesterone in 11α posi-
tion by Rhizopus nigricans was performed in a 
bench scale reactor, while the extraction was carried 
out in a microchannel system with a Y-shaped inlet 
and a multiple bended channel.58 This is one of the 
key steps in the production of corticosteroid drugs 
and hormones. The integration of reaction with flow 
extraction of progesterone and 11α-hydroxyproges-
terone from water into ethyl acetate has been sug-
gested.59 This allows increase in productivity as 
compared to the batch process both because the re-
actant is readily recovered for reuse and the product 
is easily purified. For increasing the capacity of the 
system, a numbering-up approach by using parallel 
microreactors is proposed. It is predicted that a con-
tinuous filtration unit is then needed upfront.59
Micro-flow extraction – 
Esterification to isoamyl acetate/lipase
The esterification of isoamyl alcohol and acetic 
acid to give isoamyl acetate using Lipase B (from 
Candida antarctica) was done in a microchannel re-
actor, for which all details were given above.29 Iso-
amyl acetate is one of the most employed flavors in 
food industries. An increase in temperature from 25 
to 45 °C resulted in higher reaction yields. The res-
idence time needed for the flow reaction was even 
below 1 min. Reaction rates were orders of magni-
tude higher than for batch esterification were ob-
tained at similar reactant concentrations. A further 
benefit stems from the direct coupling of the flow 
reaction to flow extraction. The enzyme is dissolved 
in aqueous phase and continuously separated from 
the organic phase (n-hexane) and the product. Li-
pase mediated synthesis of isoamyl acetate was car-
ried out in a two-phase solvent system consisting of 
a water miscible ionic liquid and n-heptane within 
ψ-shaped microfluidic device.31 Complex flow pat-
terns arise due to the amphiphilic nature of the en-
zyme causing droplet formation aside the induced 
slugs of the segmented flow. The latter is then sur-
rounded by an increasing corona of droplets (Fig. 14).
A microreactor consisting of a glass microflu-
idic chip comprising an X-junction was also used 
for this reaction in the above mentioned solvent 
S c h e m e  7  – Hydrolysis of FDG using β-galactosidase to produce fluorescein and two galactose molecules
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system. This allowed to generate high interfacial 
area for continuous product removal, and further re-
covery of the enzyme in solvent when coupled with 
a phase separator.60
Micro-flow extraction – 
Esterification to butyl butyrate/lipase
A packed-bed micro-flow reactor using immo-
bilized lipase B was coupled with a miniaturized 
separator in continuous manner for the synthesis of 
butyl butyrate using ionic liquid as a solvent. 100 % 
conversion was achieved within only 5 min at 25 °C 
and 0.5 M equimolar concentration of both the reac-
tants. The coupled separator resulted in 90 % of 
product isolation efficiency (allowing also to reuse 
the ionic liquid).61
Coupling of enzymatic micro-flow reactions 
to online-analytics
Photoionization mass spectrometry – 
Esterification to ethyl oleate/lipase
Lipid transformation was achieved in a lipase 
immobilized on a silica monolith providing a mi-
cro-flow network.62 The monolith was placed into a 
320 mm internal diameter fused silica capillary and 
such micro-flow reactor could be used up to flow 
rates of 60 mL h–1 (Fig. 15). Candida antarctica li-
pase was covalently bound onto the silica monolith 
using glutaraldehyde as the cross linking reagent. 
Triolein was quantitatively transformed into ethyl 
oleate at room temperature. No loss of activity was 
found for 15 runs. The micro-flow lipid transforma-
tions were coupled online with atmospheric pres-
sure photoionization mass spectrometry. Feasibility 
could be demonstrated, yet a further reduction of 
dead times of the prototype system is needed to en-
able the potential of such innovative analytical 
monitoring.
F i g .  1 4  – (a) Long slug of n-heptane with concave tail sur-
rounded with small droplets of n-heptane and (b) fine disper-
sion between the two neighboring n-heptane slugs (by permis-
sion of Royal Society of Chemistry31)
F i g .  1 5  – Enzymatic micro-flow reactor based on monoliths: (a) offline reaction (b) online coupled with the mass spectrometry system; 
SEM image of a cross-section of: (c) a silica monolithic capillary (1000×), (d) an enzymatic monolithic microreactor (1000×); (e) an 
NaOH-treated silica monolithic capillary (350×); (f) a non-treated silica monolithic capillary (450×) (by permission of Elsevier62)
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Multi-step enzymatic synthesis
De novo metabolic engineering offers chances 
for multi-step enzymatic synthesis to give in one 
step complex molecules.63 The pharmaceutical 
building block and diastereoisomer 2-ami-
no-1,3,4-butanetriol is synthesized from simple 
achiral substrates using two enzymes, transketolase 
(TK) and transaminase (TAm). His6-tagged TK and 
TAm were immobilized onto Ni-NTA agarose beads 
which were packed into a tube to give each an en-
zymatic micro-flow reactor. The two latter microre-
actors were cascaded in series. In a first step l-eryth-
rulose was synthesized from lithium-hydroxypyruvate 
and glycolaldehyde and thereafter converted to 
2-amino-1,3,4-butanetriol using (S)-methylbenzyl-
amine as amine donor (Scheme 8). 83 % conver-
sion was reached in 20 min at 60 mM concentra-
tion. A kinetic investigation yielded the reaction 
constant.
New Economy – Synthesis of biomass 
platform molecules
Essay: New Windows of Opportunity – 
Back to the future
The use of microreactors for valorization of 
biomolecules is gaining increasing attention. Some 
examples of biomass “platform molecules” are sug-
ars (glucose and xylose), polyols (sorbitol, glycer-
ol), furans (hydroxymethylfurfural and its deriva-
tives), acids (lactic acid, levulinic acid) and alcohols 
(ethanol).14 Platform molecules are selected based 
on their availability and potential to produce corre-
sponding intermediates and final products. Howev-
er, the production of platform chemicals often pro-
ceeds in a multi-step process with low overall 
selectivities and yields. Therefore the amount of fi-
nal product is low, costs are high and their further 
applications are limited.64 To overcome these limits, 
not only novel synthesis routes are required but – 
virtually hand in hand – also novel process technol-
ogies that will improve the efficiency of the conver-
sion processes.65 A few examples of microreactor 
technology based valorization of biomolecules are 
shown below.
Start with sugars – like in nature
5-Hydroxymethylfurfural
Biotechnical micro-flow inventions need to fol-
low the track of their chemical counterparts have 
done already.66 A new continuous production meth-
od of 5-hydroxymethylfurfural (HMF) from glucose 
and fructose in a high-pressure and high-tempera-
ture aqueous medium has been developed. Within 
10 s of reaction time a high selectivity and high 
yield in HMF synthesis were achieved. By using the 
high-pressure and high-temperature microreactor, 
heating and cooling within 0.01 s was achieved. As 
a result, production of HMF with a selectivity ex-
ceeding 80 % and yield higher than 70 % became 
possible.
S c h e m e  8  – Two step pathway for the synthesis of ABT
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L-Malic acid synthesis
Whole-cell biocatalysis was performed in flow 
in a commercially available plastic tube with per-
meabilized Saccharomyces cerevisiae cells.67 The 
modification was carried out by using 3-aminopro-
pyltriethoxysilane and glutaraldehyde. Such low 
price tagged, disposable and easy to use whole-cell 
microdevices have their promises, e.g. might lead to 
rapid optimization of the treatment time for perme-
abilization, pH of the medium and kinetic data gath-
ering. The synthesis of L-malic acid by hydration of 
fumaric acid was tested. The optimum time for per-
meabilization and pH of the medium are 6 min and 
pH-7, respectively. The volumetric and biocatalytic 
productivities of the microreactor were determined, 
and were found to be 616 mM day–1 and 11.8 mmol 
g–1ww of cells day
–1, respectively.
Oligosaccharides
As one of the first developments in the field 
of biotechnical micro-flow technology for bio-
mass platform synthesis, a silicon microreactor was 
used for the enzymatic oligosaccharide synthe-
sis.68–70 The authors reported for the first time the 
synthesis of higher oligosaccharides in a micro-de-
vice with microchannels 200 µm wide, 200 µm 
deep, and 40 cm long. The reaction between p-ni-
trophenyl-β-D-glucopyranoside (PNPGal) and ni tro-
phenyl-2-acetamide-2-deoxy-β-D-glucopyranoside 
(PNPGlcNAc) was performed using β-galactosidase 
(from Escherichia coli) (Scheme 9).
The obtained disaccharides with nitrophenyl 
group represent an important class of glycoconju-
gates. The enhancement of the reaction rate com-
pared to the micro test tube is explained by the effi-
cient diffusive mixing obtained within the 
microchannel. The microreactor synthesis enabled 
also rapid reaction optimization and faster develop-
ment of important products such as carbohydrate 
based vaccines, while batch optimization was as-
signed much more time consuming and costly.
Sugar 6-monoesters
Sugar 6-monoesters were synthesized from 
sugar and vinyl carboxylate in a micro-flow reactor 
using Lipozyme TL IM (from Thermomyces lanugi-
nosus)71 (Scheme 10). The processing was done un-
der mild reaction conditions, short reaction times 
(30 min), high yields and high regioselectivities.
S c h e m e  9  – Transglycosylation between p-nitrophenyl-β-D-glucopyranoside and nitrophenyl-2-acetamide-2-deoxy-β-D-glucopyra-
noside using β-galactosidase
S c h e m e  1 0  – General approach to give sugar 6-monoesters from sugar-vinyl carboxylate by transesterification
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Lactulose synthesis
Lactulose, non-digestible galactooligosaccha-
ride, 4-O-β-D-galactopyranosyl-D-fructose were 
synthesized in a microreactor with immobilized be-
ta-galactosidase.72 The oxygen plasma-manufac-
tured glass microreactor comprised a 13-mm-long 
trench structure with 12 channels of 390 µm width 
and 150 µm depth. The lactulose synthesis was con-
ducted for 48 h at a flow rate of 2.5 μL min–1 and 
using a concentration of 1.29 g L–1. Increase of the 
flow rate can influence lactulose synthesis, because 
of the shorter reaction time for the lactose hydroly-




The synthesis of polycaprolactone was done 
using 100 mg of Novozym 435 beads (400 +/– 50 
µm) filled into a microchannels 2 mm wide, 1 mm 
deep and 260 mm long.73 The microchannels were 
mounted on a 10 mm thick aluminum block which 
served as heating sink. Polycaprolactone is an im-
portant biodegradable polymer used in the manu-
facture of specialty polyurethanes and in biomedi-
cal applications. The enzymatic process represents a 
considerable sustainability advantage over the com-
monly used organic tin-based catalyst in the ring 
opening polymerization reaction of caprolacton. 
The tin catalyst is highly toxic and difficult to dis-
pose. Yet, there are also drawbacks of the enzymatic 
process issues which relates to catalyst stability, 
leaching and deactivation. The conversion rate in 
the microchannel reactor is higher. 90 % conversion 
is obtained within a residence time of 5 min, while 
the batch system gives 70 % conversion in 30 min. 
This is mainly due to the much higher catalyst 
 concentration per unit volume of the millireactor 
compared to the batch reactor. The micro-flow pro-
cessing provides a small molecular weight distribu-
tion which is assigned to good control of process 
conditions achievable in flow, in particular concern-
ing temperature and reaction time. This microreac-
tor platform can be easily extended to be used for 
efficient enzymatic synthesis of various biopoly-
mers.
Conclusions
Enzymatic micro-flow reactors will follow the 
enormous prospects that enzymes and biotechnolo-
gy generally have. In the just recently formed, yet 
strongly emerging bio process engineering they are 
likely to play a key role. Compared to the EDGE 
classification given above, the whole development 
is still in the “storming” phase. It is much technolo-
gy-driven and the market pull is hardly feasible. 
The devices of today may not be the devices of to-
morrow as it has been observed for their “older” 
counterparts – the chemical microreactors. These 
certainly have reached the “norming” level and 
partly the “performing” level which relates to appli-
cations and market readiness, respectively. Decisive 
will be the uptake of the new technology by indus-
try and the emerge of first commercial providers. 
There will be external stimulus as well, as given by 
the increasing capabilities of engineering enzymes 
and by the emerging bioeconomy. Thus, with hav-
ing passed the “forming” phase, for which this 
CABEQ Special Issue of the IMTB Conference is a 
powerful document, an opening of the technology 
to impacts of other disciplines is needed. Here the 
bio process engineering is urgently needed. While 
the reactor engineering is often relatively simple, 
e.g. with functionalized monoliths being filled in 
tubes, the engineering on a process and production 
level will give a new momentum and also a smart 
process control may be required.
Outlook – What’s next?
Keep speed in innovating
As mentioned in the Conclusions a large inno-
vation push is needed for the next years in develop-
ment of enzymatic micro-flow reactors. It is needed 
to merge to the flow chemistry community and 
openness for engineering solutions is needed. Cost 
arguments so far have hardly been given with very 
few exceptions.14,35,52 Benchmarking to industrial 
technology is seldom and the same holds for re-
al-life applications. Speed in innovation needs to be 
maintained and the innovations needs to weighted 
and selected by process-intensification and finally 
cost criteria.
New grounds – controlled drug release and 
tissue engineering
The multidisciplinary opening does not demand 
only for more innovations, but also new market di-
rections which simply are open for the new technol-
ogy. Controlled drug release and tissue engineering 
are new windows of opportunity; yet certainly it is 
uncertain if this will be a main future direction. In 
one such example, surface-adhered hydrogels 
equipped with enzymatic cargo served as enzymatic 
microreactors with vision for application in con-
trolled drug release and tissue engineering (Fig. 
16).74 Polyvinyl alcohol (PVA) chains with narrow 
polydispersities (1.1−1.2) and molecular weights of 
5, 10, and 28 kDa were synthesized via controlled 
radical polymerization (RAFT). The substrate-me-
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diated in-situ conversion of an externally added 
prodrug into a final product was monitored as a 
function of the polymer molecular weight and con-
centration of solution taken for assembly of the hy-
drogels. The PVA molecular weights have to be 
suitably high to give mechanically robust hydrogel 
matrices, yet need to be suitably low to allow grad-
ual degradation of the hydrogels since biodegrad-
ability is an issue for the applications under consid-
eration.
From enzymes to whole cells in flow – 
fermentations/cell cultivations
Schäpper et al. have reviewed the advantages 
of the microbioreactors over conventionally lab 
technology used in the field of fermentations/cell 
cultivations such as use of shake flasks and microti-
ter plates. The latter have limitations for reasons of 
most of the times only end-point measurement and 
non-ideal control on cultivation conditions. The use 
of microbioreactors can lead to more supple and 
well-regulated operation at bench scale in the men-
tioned field. A midterm outline on the development 
of microbioreactors is provided, coming to the main 
conclusion it will be ready to be used in the fermen-
tation industries on such timescale.75
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